A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis

Completed · Phase 2 · Has a placebo group

Conditions studied: Bacterial Vaginosis

In brief

The purpose of this research study is to test the safety and effectiveness of the oral investigational new drug, SYM-1219, for the treatment of bacterial vaginosis.

Key facts

Study ID
NCT02147899
Run by
Symbiomix Therapeutics
People needed
215
Starts
2014-05-01
Expected to finish
2014-10-01
Last updated by the study team
2020-11-13

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.